BASF (BAS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Achieved major milestones in the Winning Ways strategy, including the startup of the Zhanjiang Verbund site, accelerated cost savings, and significant organizational streamlining.
Faced a volatile and challenging global market in 2025, with strong headwinds for the chemical industry and a focus on controllable factors.
FY 2025 saw higher volumes but was impacted by negative currency effects and lower prices, leading to a 2.9% decline in sales year-over-year.
EBITDA before special items fell 9.5% to €6,554m, mainly due to upstream margin pressure and currency headwinds.
Net income rose to €1.6 billion, supported by portfolio gains and special income from reimbursements related to expropriated Russian assets.
Financial highlights
Sales declined considerably year-over-year in Q4 2025 due to currency headwinds and lower prices, despite slightly higher volumes in most segments.
EBITDA before special items was €1.03 billion in Q4 (down 27.9%), and €6.6 billion for the full year (down from 2024), mainly due to lower margins and negative currency effects.
Net income improved by 25% to €1.6 billion, with net income from shareholdings rising to €1.3 billion, driven by Wintershall Dea and special income.
Free cash flow increased to €1.3 billion, aided by reduced capex.
Net debt reduced to €18.3 billion by year-end; equity ratio stable at 45.1%.
Outlook and guidance
2026 guidance: EBITDA before special items expected between €6.2–7.0 billion; free cash flow between €1.5–2.3 billion.
No meaningful market upswing or easing of geopolitical tensions expected in the near term; gradual recovery anticipated in late 2026 and 2027.
CapEx planned at €3.3–3.4 billion in 2026, with a four-year plan of €13 billion (20% lower than previous forecast).
Dividend proposal of €2.25 per share (5.1% yield), with at least €12 billion to be distributed to shareholders via dividends and buybacks by 2028.
Segment outlook: Chemicals and Nutrition & Care to see considerable EBITDA increases; Materials, Surface Technologies, and Agricultural Solutions to decline.
Latest events from BASF
- On track for net-zero by 2050, with strong advances in renewables and sustainable product sales.BAS
Investor presentation27 Feb 2026 - EBITDA fell but net income and free cash flow rose, driven by cost savings and portfolio actions.BAS
Q4 2025 (Media)27 Feb 2026 - Sales and earnings fell amid margin pressure, but portfolio actions and buybacks boost resilience.BAS
Q3 2025 (Media)3 Feb 2026 - EBITDA stable at €2.0 billion despite sales decline; cost savings and guidance unchanged.BAS
Q2 20242 Feb 2026 - Targets €10–12bn EBITDA, €12bn+ returns, and green growth by 2028 with a focus on core businesses.BAS
CMD 2024 Day 120 Jan 2026 - Targets €12B in shareholder returns, €10–12B EBITDA, and accelerated green transformation.BAS
CMD 2024 Day 220 Jan 2026 - EBITDA before special items rose 5% to €1.62 billion, but free cash flow fell sharply.BAS
Q3 202418 Jan 2026 - Core business margins improved, but free cash flow and Surface Tech earnings declined sharply.BAS
Q3 2024 (Media)18 Jan 2026 - EBITDA and net income rose in 2024, with 2025 set for further growth and portfolio action.BAS
Q4 20247 Jan 2026